Media coverage
1
Media coverage
Title NICE recommends weight loss drug semaglutide for obese adults Degree of recognition International Media name/outlet BMJ Country/Territory United Kingdom Date 8/02/22 Description Commenting on the guidance, Akheel Syed, a consultant endocrinologist at Salford Royal NHS Foundation Trust, welcomed the recommendation, noting that although a similar once-daily weight loss treatment (liraglutide) was already available, semaglutide had the “advantage of once weekly administration, which is much better for patients, and has superior efficacy.” He added that the recommendation of lower BMI thresholds for people from some ethnic minorities, “in recognition of their higher risk of morbidity from obesity, is particularly welcome.”
However, Syed emphasised that “equitable access to
novel and expensive medical treatments remains an
issue up and down the country,” and he called for
better funding to “ensure the best care for patients
with obesity.”URL https://doi.org/10.1136/bmj.o340 Persons Akheel Syed